# Everolimus

NDC: 70377-090
Generic name: Everolimus
Labeler / Manufacturer: Biocon Pharma Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FOR SUSPENSION
Routes: ORAL
Marketing started: 20260114

FDA application: ANDA217216

## Active ingredients

- EVEROLIMUS: 2 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70377-090"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70377-090
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5b809dfe-c076-07c5-207e-178c3f0d32d3